Cristina Galvez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 995 Sperry Ave, Patterson, CA 95363 Phone: 209-894-3700 |
Dr. Henry Gnesa, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1035 Sperry Ave, Patterson, CA 95363 Phone: 209-892-4545 |
Margaret Kelly-mcgarry Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1035 Sperry Ave, Patterson, CA 95363 Phone: 209-892-4545 Fax: 209-892-5897 |
Samuel Rodriguez, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 995 Sperry Ave, Patterson, CA 95363 Phone: 209-894-3700 Fax: 209-894-3704 |
Pamela Mccullough Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1030 Sperry Ave, Patterson, CA 95363 Phone: 209-895-4420 |
Dr. Alisha Danielle Wright, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 S Del Puerto Ave, Patterson, CA 95363 Phone: 209-892-8444 Fax: 209-892-8472 |
Dr. Mandeep Kaur Grewal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1030 Sperry Ave, Patterson, CA 95363 Phone: 209-895-4420 |
Sukhtaz Dhaliwal, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1030 Sperry Ave, Patterson, CA 95363 Phone: 209-895-4420 |
Dr. Mark James Lawicki, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 995 Sperry Ave, Patterson, CA 95363 Phone: 209-894-3700 Fax: 209-894-3707 |
Steven A Moeller Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1030 Sperry Ave, Patterson, CA 95363 Phone: 209-895-4420 |
Dr. Mojdeh Khosravan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1080 Sperry Ave, Patterson, CA 95363 Phone: 209-892-5584 |
Dr. William Thomas Bragdon Jr., PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 Ward Ave, Building B, Suite #6, Patterson, CA 95363 Phone: 209-892-8444 |
Dr. John F Wong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 Ward Ave, Bldg B Suite #6, Patterson, CA 95363 Phone: 209-892-8444 Fax: 209-892-8472 |
Heather Enos Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1080 Sperry Ave, Patterson, CA 95363 Phone: 209-892-6182 |
Gulalai Wardak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1080 Sperry Ave, Patterson, CA 95363 Phone: 209-892-5584 |
News Archive
The Human Microbiome Project (HMP) is a global initiative to identify and characterize the microorganisms present at multiple sites in the human body.
In advance of what is shaping up to be an unprecedented flu season, Ontario's doctors are encouraging employers to reconsider asking their employees for a sick note from a physician because of an absence from work.
USA Today: "As health care costs soared nationally, a small Michigan firm gave Ford Motor Co. a proposal to cut its physical therapy costs. The automaker signed up for an in-state pilot program, which was so successful Ford expanded it last year to cover about 390,000 employees, retirees and their families nationwide." But court "records allege Blue Cross used its position as the state's dominant insurer to try to crush TheraMatrix as it worked to also sign up Chrysler and General Motors.
The Medical Home Network collaboration in Chicago is changing the way health care is being delivered to Medicaid patients through the use of innovative technology combined with a highly efficient, patient-centered and team-based model of care, according to information released October 15. This has an impact on hospital readmissions, the length of hospital stay and the cost of providing care. Rush University Medical Center is one six founding hospital partners.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced it has entered into an agreement providing for an Equity Line Facility (ELF) with Dutchess Opportunity Cayman Fund Ltd., a fund managed by Dutchess Capital Management, II LLC. Under the terms of the ELF, Dutchess has committed to provide up to $10 million of capital during the next two years, at LAB Research's discretion, through the subscription of newly issued common shares.
› Verified 6 days ago